Meta Platforms Will Be a $3 Trillion Company By This Date

Photo of Vandita Jadeja
By Vandita Jadeja Published

Quick Read

  • Meta (META) posted Q1 2026 revenue of $56.31B, up 33.1% YoY, with EPS of $10.44 crushing consensus by 57%, driven by 19% growth in ad impressions and 12% rise in price per ad while the stock trades 11% below its price one month ago.

  • Meta’s $125-145B 2026 capex investment in AI infrastructure is meant to sustain advertising dominance against generative AI competitors and fund its superintelligence roadmap, positioning the company toward a $3 trillion market cap by 2030.

  • The analyst who called NVIDIA in 2010 just named his top 10 stocks and Meta wasn't one of them. Get them here FREE.

Meta Platforms Will Be a $3 Trillion Company By This Date

© Derick Hudson / iStock Editorial via Getty Images

Meta Platforms (NASDAQ:META | META Price Prediction) is in an awkward stretch. The stock sits 11.23% below where it traded a month ago, yet the business just printed its strongest growth quarter in years.

Our 24/7 Wall St. price target for Meta is $860.03 over the next 12 months, implying 40.71% upside from the $611.21 close. The recommendation is buy at a 90% confidence level. Stretch the model five years, and Meta crosses the $3 trillion market cap line.

Metric Value
Current Price $611.21
24/7 Wall St. Price Target $860.03
Upside 40.71%
Recommendation BUY
Confidence Level 90%

A Pullback That Masks an Accelerating Business

Meta is down 7.33% year to date and 4.25% over the trailing year, trading 4% below the 52-week high of $794.38. The Q1 2026 report on April 29 told a different story than the chart.

Revenue of $56.31 billion grew 33.1% YoY, ad impressions rose 19%, and price per ad climbed 12%. EPS of $10.44 blew past the $6.66 consensus, the fifth straight beat, helped by an $8.03 billion CAMT tax benefit (operational EPS still cleared $7.31). Family daily active people reached 3.56 billion.

An infographic titled 'Meta Platforms (NASDAQ: META) 12-Month Price Prediction' by 24/7 Wall St. is presented on a dark gray and green background. The top section, 'The Call', displays an arrow from $611.21 to $860.03, showing an 'Upside percentage' of +40.71% and a large 'BUY' button with 'Confidence: 90%'. The 'How We Got There' section lists 'Forward P/E-Based Price: $804.93', 'Analyst Consensus: $826.69', and 'Pre-Adjustment Price: $772.71'. 'Our Adjustments' details a '247Factor: 1.113 (Bullish Skew, Earnings Acceleration)' and shows 'Pre-Adjustment Price: $772.71' leading to a 'Final Target: $860.03'. The 'BULL CASE: What Could Go Right' section lists three points with upward-trending graph icons: 'Strong Ad Revenue Growth (+33.1% YoY in Q1 2026)', 'AI Infrastructure Investment (Meta Superintelligence Labs, $125-145B Capex)', and 'Strong Analyst Support (89% Bullish, 0 Sells)'. The 'BEAR CASE: What Could Go Wrong' section lists three points with warning triangle icons: 'Reality Labs Losses ($19.2B in 2025, $4.03B Q1 2026)', 'Regulatory Risks & Litigation (EU DMA, US Youth Trials)', and 'Heavy Capex Ramp (Total costs +35% YoY in Q1)'. The 'THE BOTTOM LINE' section reiterates a 'BUY' recommendation, states '$860.03 (+40.71%)', and provides a '5-Year Outlook: On track to cross $3 Trillion market cap milestone during 2030, with a 2031 base case of $1,583.41.'
24/7 Wall St.

Why Bulls See a Breakout Ahead

The bull case rests on advertising compounding while AI infrastructure converts into pricing power. Sell-side coverage shows 9 strong buy and 47 buy ratings against zero sells, with the Street target of $826.69 sitting close to our base case.

Mark Zuckerberg framed the quarter bluntly: “We had a milestone quarter with strong momentum across our apps and the release of our first model from Meta Superintelligence Labs.” The $125 to $145 billion 2026 capex plan funds the GPU stack underneath that ambition. Our model’s bull scenario one year out is $890.59, and net insider direction is buying.

The Risks Worth Watching

Reality Labs lost $19.2 billion across 2025 and another $4.03 billion in Q1 2026. Total costs grew 35% in Q1, slightly outpacing revenue, and U.S. youth-related litigation has trials on the 2026 calendar that could produce a material charge. EU pressure under the Digital Markets Act remains an open file.

Bulls would counter that the capex surge is the investment Meta needs to defend its ad franchise against generative competitors, and Reality Labs losses have actually narrowed sequentially. Our bear scenario still lands at $742.49, a 21.48% return.

Our Take at $611

At $611, the setup looks favorable for investors who can tolerate the capex headlines and the litigation overhang. The 24/7 Wall St. price target of $860.03, a buy rating, and 90% confidence reflect a business compounding at 33% revenue growth with a 22 trailing P/E. I’d stay sidelined if youth litigation produces a multi-billion-dollar verdict or if 2027 capex guidance keeps climbing without ad revenue follow-through.

Meta Platforms Price Prediction 2026-2030

At 2.196 billion shares outstanding, a $3 trillion market cap requires roughly $1,366 per share. Our 5-year base case is $1,583.41 by May 2031, meaning Meta is on track to cross the $3 trillion line during 2030.

Year 24/7 Wall St. Price Target
2026 $860
2027 $1,015
2028 $1,185
2029 $1,360
2030 $1,520

These projections assume Meta executes on its superintelligence roadmap and ad pricing holds. A regulatory setback in the EU or a sustained capex overshoot without monetization could push the $3 trillion date into 2031.

Photo of Vandita Jadeja
About the Author Vandita Jadeja →

Vandita Jadeja is a financial copywriter who loves to read and write about stocks. She believes in buying and holding for long term gains. Her knowledge of words and numbers helps her write clear stock analysis. She has contributed to several publications, including the Joy Wallet, Benzinga, The Motley Fool and InvestorPlace.

Continue Reading

Top Gaining Stocks

MU Vol: 49,901,452
DXCM Vol: 6,420,139
KR Vol: 4,459,716
BDX Vol: 2,294,408
EQT
EQT Vol: 5,316,877

Top Losing Stocks

CTRA Vol: 73,319,495
EL Vol: 2,405,799
NEM Vol: 5,330,083
MRNA Vol: 3,322,584
ENPH Vol: 6,007,392